Prohibition Partners
Home / Reports & Data / The European CBD Report: Health & Wellness
ReportEurope

The European CBD Report: Health & Wellness

Specific laws and regulations for CBD are lagging far behind the evolution of the market, meaning CBD is now potentially the largest CPG product in Europe which is, in the majority, sold under legally ‘grey’ conditions.

  • Analyst-written market analysis
  • PDF + data
  • Published 2022

Cited in boardrooms, legal proceedings & government briefings since 2017. Our figures are built to be defended — sourced, modelled and signed off by PP’s analysts.

Trusted by teams at

DIAGEOKPMGBarclaysNovartisBloomberg

About this edition

Specific laws and regulations for CBD are lagging far behind the evolution of the market, meaning CBD is now potentially the largest CPG product in Europe which is, in the majority, sold under legally ‘grey’ conditions. It combines PP’s proprietary market sizing with regulatory analysis, giving investors and corporates a single, citable reference — delivered digitally, licensed for internal use, and backed by the analysts who built the numbers.

PDF + data

delivery format

2022

published

Inside this edition

Overview

CBD is now one of the most popular wellness products in Europe, with about 11% of respondents to Prohibition Partners' new European survey indicating some usage over the past 12 months. CBD-specific ‘bricks and mortar' stores are popping up in virtually every country on the continent and the industry is generating hundreds of millions of euro in revenue each year. However, the legislative and regulatory environment that guides this market is extremely changeable and heterogenous across Europe. Operators need to be acutely aware of these changes as they are driving the business opportunities on the continent.

Contents6
  • Legislation
  • CBD Sub Markets
  • Compliance
  • Supply chain
  • European CBD survey
  • Market Development
Key findings7
  • CBD is now one of the most popular wellness products in Europe, with about 11% of respondents to Prohibition Partners' new European survey indicating some usage over the past 12 months.
  • In November 2020, the European Court of Justice (ECJ) declared that CBD cannot be considered a narcotic substance under the European Union (EU) interpretation of the United Nations Single Convention on Narcotic Drugs (UNODC).
  • The next major step for CBD in the EU and the United Kingdom (UK) is the acceptance of CBD products into the Novel Food Catalogue, under each jurisdiction.
  • The supply of CBD into Europe is currently able to meet the market demands, and there is very likely an oversupply in terms of the raw material.
  • The cultivation of hemp for CBD across Europe is still popular, especially in hubs such as the Baltic nations, Italy, Switzerland and the Netherlands. However, producers have been competing with imports from the United States (US) which massively expanded in 2019.
  • CBD consumer practices in Europe are changing quite rapidly, and as CBD has no international trading codes, and most companies are operating in a legally ‘grey' space, there is a dearth of data on consumption patterns.
  • Specific laws and regulations for CBD are lagging far behind the evolution of the market, meaning CBD is now potentially the largest CPG product in Europe which is, in the majority, sold under legally ‘grey' conditions.

Who it’s for

Investors & analysts

Defensible sizing and forecasts to underwrite the thesis.

Corporate strategy & FMCG

Opportunity sizing and entry routes across key markets.

More from the library

All research